STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9655-9672

  Dulek, Daniel E ^a   Newcomb, Dawn C ^a   Toki, Shinji ^a   Goliniewska, Kasia ^a   Cephus, Jacqueline ^a   Reiss, Sara ^a   Bates, John T ^a   Crowe, James E ^a   Boyd, Kelli L ^a   Moore, Martin L ^b   Zhou, Weisong ^a   Peebles, R Stokes ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT4 PROTEIN; STAT4 PROTEIN, MOUSE;

ANIMAL; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; DEFICIENCY; DISEASE MODEL; FEMALE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; PATHOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH17 CELL; TH2 CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE, INBRED BALB C; MICE, KNOCKOUT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; STAT4 TRANSCRIPTION FACTOR; TH17 CELLS; TH2 CELLS;

EID: 84921967041     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03299-13     Document Type: Article

References (83)

1. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. 2009. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360:588-598. http://dx.doi.org/10.1056/NEJMoa0804877.
2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352:1749-1759. http://dx.doi.org/10.1056/NEJMoa043951.
3. Collins PL, Melero JA. 2011. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162: 80-99. http://dx.doi.org/10.1016/j.virusres.2011.09.020.
4. Graham BS. 2011. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol. Rev. 239: 149-166. http://dx.doi.org/10.1111/j.1600-065X.2010.00972.x.
5. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. 1970. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23:7-18. http://dx.doi.org/10.1136/jcp.23.1.7.
6. Peebles RS, Jr, Graham BS. 2005. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc. Am. Thorac. Soc. 2:110-115. http://dx.doi.org/10.1513/pats.200501-002AW.
7. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. 2007. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20:108-119. http://dx.doi.org/10.1038/modpathol.3800725.
8. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944-2952. http://dx.doi.org/10.4049/jimmunol.168.6.2944.
9. Li F, Zhu H, Sun R, Wei H, Tian Z. 2012. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J. Virol. 86:2251-2258. http://dx.doi.org/10.1128/JVI.06209-11.
10. Cannon MJ, Openshaw PJ, Askonas BA. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168. http://dx.doi.org/10.1084/jem.168.3.1163.
11. Graham BS, Bunton LA, Wright PF, Karzon DT. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026-1033. http://dx.doi.org/10.1172/JCI115362.
12. Graham BS, Perkins MD, Wright PF, Karzon DT. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162. http://dx.doi.org/10.1002/jmv.1890260207.
13. Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS, Jr. 2005. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116:550-557. http://dx.doi.org/10.1016/j.jaci.2005.03.051.
14. Lukacs NW, Moore ML, Rudd BD, Berlin AA, Collins RD, Olson SJ, Ho SB, Peebles RS, Jr. 2006. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am. J. Pathol. 169:977-986. http://dx.doi.org/10.2353/ajpath.2006.051055.
15. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, Lee S, Goleniewska K, Pretto C, Williams JV, Hotard A, Sherrill TP, Peebles RS, Jr, Moore ML. 2011. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 85: 5782-5793. http://dx.doi.org/10.1128/JVI.01693-10.
16. Kaplan MH. 2005. STAT4: a critical regulator of inflammation in vivo. Immunol. Res. 31:231-242. http://dx.doi.org/10.1385/IR:31:3:231.
17. Kaplan MH, Sun YL, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177. http://dx.doi.org/10.1038/382174a0.
18. Schulz EG, Mariani L, Radbruch A, Hofer T. 2009. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 30:673-683. http://dx.doi.org/10.1016/j.immuni.2009.03.013.
19. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihle JN. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174. http://dx.doi.org/10.1038/382171a0.
20. Thieu VT, Yu Q, Chang HC, Yeh N, Nguyen ET, Sehra S, Kaplan MH. 2008. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29:679-690. http://dx.doi.org/10.1016/j.immuni.2008.08.017.
21. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:549-557. http://dx.doi.org/10.1038/ni794.
22. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao TP, Yang SY, Reiner SL. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-1910. http://dx.doi.org/10.1126/science.1059835.
23. Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O'Shea JJ, Biron CA. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297:2063-2066. http://dx.doi.org/10.1126/science.1074900.
24. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338-342. http://dx.doi.org/10.1126/science.1065543.
25. Usui T, Preiss JC, Kanno Y, Yao ZJ, Bream JH, O'Shea JJ, Strober W. 2006. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203:755-766. http://dx.doi.org/10.1084/jem.20052165.
26. Gil MP, Ploquin MJ, Watford WT, Lee SH, Kim K, Wang X, Kanno Y, O'Shea JJ, Biron CA. 2012. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 120:3718-3728. http://dx.doi.org/10.1182/blood-2012-05-428672.
27. Agarwal P, Raghavan A, Nandiwada SL, Curtsinger JM, Bohjanen PR, Mueller DL, Mescher MF. 2009. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183:1695-1704. http://dx.doi.org/10.4049/jimmunol.0900592.
28. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174:4465-4469. http://dx.doi.org/10.4049/jimmunol.174.8.4465.
29. Mack EA, Kallal LE, Demers DA, Biron CA. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. mBio 2(4):e00169-11. http://dx.doi.org/10.1128/mBio.00169-11.
30. Miyagi T, Gil MP, Wang X, Louten J, Chu WM, Biron CA. 2007. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204:2383-2396. http://dx.doi.org/10.1084/jem.20070401.
31. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287. http://dx.doi.org/10.4049/jimmunol.169.8.4279.
32. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669. http://dx.doi.org/10.1016/S0092-8674(00)80702-3.
33. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8:145-153. http://dx.doi.org/10.1038/ni1424.
34. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307:430-433. http://dx.doi.org/10.1126/science.1103336.
35. Fujiwara M, Hirose K, Kagami S, Takatori H, Wakashin H, Tamachi T, Watanabe N, Saito Y, Iwamoto I, Nakajima H. 2007. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 119:662-670. http://dx.doi.org/10.1016/j.jaci.2006.12.643.
36. Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH. 2011. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12:96-104. http://dx.doi.org/10.1038/ni.1969.
37. Oestreich KJ, Weinmann AS. 2012. T-bet employs diverse regulatory mechanisms to repress transcription. Trends Immunol. 33:78-83. http://dx.doi.org/10.1016/j.it.2011.10.005.
38. Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G, Guo L, Yagi R, Yamane H, Punkosdy G, Feigenbaum L, Zhao K, Paul WE. 2012. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37:660-673. http://dx.doi.org/10.1016/j.immuni.2012.09.007.
39. Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, Kaplan MH, Lukacs NW. 2001. Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am. J. Pathol. 159:631-638. http://dx.doi.org/10.1016/S0002-9440(10)61734-8.
40. Tekkanat KK, Maassab HF, Cho DS, Lai JJ, John A, Berlin A, Kaplan MH, Lukacs NW. 2001. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J. Immunol. 166:3542-3548. http://dx.doi.org/10.4049/jimmunol.166.5.3542.
41. Furuta S, Kagami S, Tamachi T, Ikeda K, Fujiwara M, Suto A, Hirose K, Watanabe N, Saito Y, Iwamoto I, Nakajima H. 2008. Overlapping and distinct roles of STAT4 and T-bet in the regulation of T cell differentiation and allergic airway inflammation. J. Immunol. 180:6656-6662. http://dx.doi.org/10.4049/jimmunol.180.10.6656.
42. Bot A, Rodrigo E, Wolfe T, Bot S, Von Herrath MG. 2003. Infectiontriggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J. Virol. 77:5794-5800. http://dx.doi.org/10.1128/JVI.77.10.5794-5800.2003.
43. Raman K, Kaplan MH, Hogaboam CM, Berlin A, Lukacs NW. 2003. STAT4 signal pathways regulate inflammation and airway physiology changes in allergic airway inflammation locally via alteration of chemokines. J. Immunol. 170:3859-3865. http://dx.doi.org/10.4049/jimmunol.170.7.3859.
44. Kim YS, Choi SJ, Choi JP, Jeon SG, Oh S, Lee BJ, Gho YS, Lee CG, Zhu Z, Elias JA, Kim YK. 2010. IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model. Exp. Mol. Med. 42:533-546. http://dx.doi.org/10.3858/emm.2010.42.8.054.
45. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC.
46. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE, Jr, Goleniewska K, Williams JV, Collins PL, Peebles RS, Jr. 2009. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J. Virol. 83:4185-4194. http://dx.doi.org/10.1128/JVI.01853-08.
47. Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE, Jr. 2013. Reversion of somatic mutations of the respiratory syncytial virusspecific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. J. Immunol. 190:3732-3739. http://dx.doi.org/10.4049/jimmunol.1202964.
48. Newcomb DC, Boswell MG, Huckabee MM, Goleniewska K, Dulek DE, Reiss S, Lukacs NW, Kolls JK, Peebles RS, Jr. 2012. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J. Immunol. 188: 1027-1035. http://dx.doi.org/10.4049/jimmunol.1102216.
49. Erickson JJ, Gilchuk P, Hastings AK, Tollefson SJ, Johnson M, Downing MB, Boyd KL, Johnson JE, Kim AS, Joyce S, Williams JV. 2012. Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J. Clin. Invest. 122:2967-2982. http://dx.doi.org/10.1172/JCI62860.
50. Hahn YS, Hahn CS, Braciale VL, Braciale TJ, Rice CM. 1992. CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335-1341. http://dx.doi.org/10.1084/jem.176.5.1335.
51. McGill J, Van Rooijen N, Legge KL. 2008. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 205:1635-1646. http://dx.doi.org/10.1084/jem.20080314.
52. Lazarevic V, Glimcher LH. 2011. T-bet in disease. Nat. Immunol. 12: 597-606. http://dx.doi.org/10.1038/ni.2059.
53. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596. http://dx.doi.org/10.1016/S0092-8674(00)80240-8.
54. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133. http://dx.doi.org/10.1016/j.cell.2006.07.035.
55. Oestreich KJ, Weinmann AS. 2012. Transcriptional mechanisms that regulate T helper 1 cell differentiation. Curr. Opin. Immunol. 24:191-195. http://dx.doi.org/10.1016/j.coi.2011.12.004.
56. Carter LL, Murphy KM. 1999. Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J. Exp. Med. 189:1355-1360. http://dx.doi.org/10.1084/jem.189.8.1355.
57. Li Q, Eppolito C, Odunsi K, Shrikant PA. 2006. IL-12-programmed long-term CD8+T cell responses require STAT4. J. Immunol. 177:7618-7625. http://dx.doi.org/10.4049/jimmunol.177.11.7618.
58. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. U. S. A. 100:15818-15823. http://dx.doi.org/10.1073/pnas.2636938100.
59. Kulkarni AB, Connors M, Firestone CY, Morse HC, III, Murphy BR. 1993. The cytolytic activity of pulmonary CD8+lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J. Virol. 67:1044-1049.
60. Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE, Jr, Murphy BR. 1995. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69:1261-1264.
61. Hwang I, Scott JM, Kakarla T, Duriancik DM, Choi S, Cho C, Lee T, Park H, French AR, Beli E, Gardner E, Kim S. 2012. Activation mechanisms of natural killer cells during influenza virus infection. PLoS One 7:e51858. http://dx.doi.org/10.1371/journal.pone.0051858.
62. Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ. 2010. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J. Virol. 84: 4073-4082. http://dx.doi.org/10.1128/JVI.02014-09.
63. Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS. 2010. NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J. Immunol. 185:4681-4690. http://dx.doi.org/10.4049/jimmunol.1001758.
64. Hussell T, Openshaw PJ. 1998. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 79(Part 11):2593-2601.
65. Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. 1991. Respiratory syncytial virus infection in anti-mu-treated mice. J. Virol. 65:4936-4942.
66. Hunter CA, Kastelein R. 2012. Interleukin-27: balancing protective and pathological immunity. Immunity 37:960-969. http://dx.doi.org/10.1016/j.immuni.2012.11.003.
67. Yoo JK, Kim TS, Hufford MM, Braciale TJ. 2013. Viral infection of the lung: host response and sequelae. J. Allergy Clin. Immunol. 132:1263-1276, quiz 1277. http://dx.doi.org/10.1016/j.jaci.2013.06.006.
68. Graham BS, Bunton LA, Wright PF, Karzon DT. 1991. Reinfection of mice with respiratory syncytial virus. J. Med. Virol. 34:7-13. http://dx.doi.org/10.1002/jmv.1890340103.
69. Haynes LM, Tonkin J, Anderson LJ, Tripp RA. 2002. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection. J. Virol. 76:6873-6881. http://dx.doi.org/10.1128/JVI.76.14.6873-6881.2002.
70. Schmitt N, Bustamante J, Bourdery L, Bentebibel SE, Boisson-Dupuis S, Hamlin F, Tran MV, Blankenship D, Pascual V, Savino DA, Banchereau J, Casanova JL, Ueno H. 2013. IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood 121:3375-3385. http://dx.doi.org/10.1182/blood-2012-08-448902.
71. Culley FJ, Pollott J, Openshaw PJ. 2002. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196:1381-1386. http://dx.doi.org/10.1084/jem.20020943.
72. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW. 2005. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol. 175:1876-1883. http://dx.doi.org/10.4049/jimmunol.175.3.1876.
73. Lee YM, Miyahara N, Takeda K, Prpich J, Oh A, Balhorn A, Joetham A, Gelfand EW, Dakhama A. 2008. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 177:208-218. http://dx.doi.org/10.1164/rccm.200612-1890OC.
74. Rauch I, Muller M, Decker T. 2013. The regulation of inflammation by interferons and their STATs. JAKSTAT 2:e23820. http://dx.doi.org/10.4161/jkst.23820.
75. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. 2004. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202:139-156. http://dx.doi.org/10.1111/j.0105-2896.2004.00211.x.
76. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178:4901-4907. http://dx.doi.org/10.4049/jimmunol.178.8.4901.
77. Villarino AV, Gallo E, Abbas AK. 2010. STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and-independent mechanisms. J. Immunol. 185:6461-6471. http://dx.doi.org/10.4049/jimmunol.1001343.
78. Fukao T, Frucht DM, Yap G, Gadina M, O'Shea JJ, Koyasu S. 2001. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166: 4446-4455. http://dx.doi.org/10.4049/jimmunol.166.7.4446.
79. Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H, O'Shea JJ. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164: 4659-4664. http://dx.doi.org/10.4049/jimmunol.164.9.4659.
80. Remoli ME, Ragimbeau J, Giacomini E, Gafa V, Severa M, Lande R, Pellegrini S, Coccia EM. 2007. NF-kappaB is required for STAT-4 expression during dendritic cell maturation. J. Leukoc. Biol. 81:355-363. http://dx.doi.org/10.1189/jlb.0506319.
81. Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF. 2008. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin. Infect. Dis. 46:50-57. http://dx.doi.org/10.1086/524019.
82. Ostler T, Hussell T, Surh CD, Openshaw P, Ehl S. 2001. Long-term persistence and reactivation ofTcellmemoryin the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol. 31:2574-2582. http://dx.doi.org/10.1002/1521-4141(200109)31:9<2574::AID-IMMU2574>3.0.CO;2-V.
83. Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL. 2006. Cutting edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J. Immunol. 177:7515-7519. http://dx.doi.org/10.4049/jimmunol.177.11.7515.